ArticleJournal of controlled release : official journal of the Controlled Release Society2020

Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session.

Marion M Deken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.